PT - JOURNAL ARTICLE AU - April W. Armstrong AU - Joel M. Gelfand AU - Wolf-Henning Boehncke AU - Ehrin J. Armstrong TI - Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting AID - 10.3899/jrheum.130457 DP - 2013 Aug 01 TA - The Journal of Rheumatology PG - 1434--1437 VI - 40 IP - 8 4099 - http://www.jrheum.org/content/40/8/1434.short 4100 - http://www.jrheum.org/content/40/8/1434.full SO - J Rheumatol2013 Aug 01; 40 AB - At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) in Stockholm, Sweden, several GRAPPA members led a panel discussion on cardiovascular (CV) comorbidities of psoriasis and psoriatic arthritis (PsA). The panelists discussed the role of insulin resistance in the pathophysiology of psoriasis, the possible effect of tumor necrosis factor inhibitors on CV comorbidities, and the effect of 12/23 monoclonal antibodies on CV outcomes. The panelists also addressed how lessons from CV comorbidity research could be applied to other areas of comorbidity research in psoriasis and PsA and identified future research directions in this area.